Raymond James & Associates Cuts Stock Holdings in Relx PLC (NYSE:RELX)

Raymond James & Associates reduced its position in shares of Relx PLC (NYSE:RELX) by 5.4% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 973,202 shares of the technology company’s stock after selling 56,047 shares during the period. Raymond James & Associates’ holdings in Relx were worth $22,929,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of RELX. CWM LLC increased its stake in Relx by 178.5% during the 1st quarter. CWM LLC now owns 1,810 shares of the technology company’s stock worth $39,000 after buying an additional 1,160 shares in the last quarter. Ellevest Inc. boosted its holdings in shares of Relx by 63.8% during the 1st quarter. Ellevest Inc. now owns 1,944 shares of the technology company’s stock worth $42,000 after purchasing an additional 757 shares during the last quarter. Toronto Dominion Bank boosted its holdings in shares of Relx by 103.1% during the 1st quarter. Toronto Dominion Bank now owns 2,640 shares of the technology company’s stock worth $57,000 after purchasing an additional 1,340 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Relx by 149.1% during the 2nd quarter. Parallel Advisors LLC now owns 2,972 shares of the technology company’s stock worth $70,000 after purchasing an additional 1,779 shares during the last quarter. Finally, FMR LLC boosted its holdings in shares of Relx by 10.9% during the 1st quarter. FMR LLC now owns 5,058 shares of the technology company’s stock worth $108,000 after purchasing an additional 498 shares during the last quarter. Institutional investors own 3.09% of the company’s stock.

NYSE:RELX opened at $21.17 on Friday. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.42 and a current ratio of 0.47. The stock’s fifty day moving average is $22.98 and its two-hundred day moving average is $23.41. Relx PLC has a 52 week low of $16.81 and a 52 week high of $27.25.

The company also recently declared a semi-annual dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Monday, August 3rd will be paid a dividend of $0.1725 per share. This represents a yield of 2.7%. The ex-dividend date is Friday, July 31st. Relx’s dividend payout ratio (DPR) is 66.39%.

RELX has been the topic of several recent research reports. JPMorgan Chase & Co. restated an “overweight” rating on shares of Relx in a report on Thursday, April 9th. Barclays restated an “overweight” rating on shares of Relx in a report on Tuesday, July 7th. UBS Group restated a “neutral” rating on shares of Relx in a report on Wednesday, July 15th. Zacks Investment Research cut Relx from a “hold” rating to a “sell” rating in a report on Friday, July 24th. Finally, ABN Amro cut Relx from a “buy” rating to a “hold” rating in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $26.00.

Relx Company Profile

RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.

See Also: What is a Special Dividend?

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx PLC (NYSE:RELX).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.